logo
Plus   Neg
Share
Email

AstraZeneca: FDA Issues Complete Response Letter For ZS-9 - Quick Facts

AstraZeneca (AZN.L) announced the US FDA has issued a Complete Response Letter regarding the New Drug Application (NDA) for ZS-9 (sodium zirconium cyclosilicate). The CRL followed an inspection by the FDA of the ZS-9 manufacturing facility. The CRL does not require the generation of any new clinical data.

Sodium zirconium cyclosilicate is being developed for the treatment of hyperkalaemia by ZS Pharma, a subsidiary of AstraZeneca.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Carlos Torres Vila, CEO of the Spanish bank Banco Bilbao Vizcaya Argentaria SA or BBVA , warned that blockchain technology is not mature and faces significant challenges, el Economista reported. However, he believes the advantages of blockchain technology are so important to their business. Down the line, GE has transformed from a too-big-to-fail conglomerate to a too-big-for-success albatross. The company has admitted to being too-much focused on EPS and operating profit, and not paying enough attention to cash. However, GE is certainly learning lessons from its past and refocusing its strategies to stage a comeback to its Camelot days, the key catalysts being... Industrial conglomerate General Electric Co., one of the original components of the Dow Jones Industrial Average, has been replaced by Walgreens Boots Alliance Inc. in the blue-chip index. The change comes into effect prior to the open of trading on Tuesday, June 26. The 122-year-old Dow Jones Industrial Average, or simply the Dow, is a stock market index with 30 component companies.
Follow RTT